Firan Technology Group gets price target raise at Beacon Securities

Beacon Securities analyst Gabriel Leung says Firan Technology Group (Firan Technology Group Stock Quote, Chart TSX:FTG) delivered quarterly results that were a little light on revenue but indicated that healthier profit margins are likely to continue going forward.

As a result, FTG got a target price bump from Leung in a client update delivered on Thursday in which the analyst reiterated his “Buy” rating on the stock.

Aerospace and defense electronics company Firan reported its fiscal first quarter on Wednesday, generating revenue and EBITDA of $25.4 million and $3.3 million, respectively. The top line was lower than Leung’s $29.3 million estimate but the EBITDA was in-line with the analyst’s own $3.3 million.

Leung points out that the company’s Q1 revenues were impacted negatively by continued material shortages and certain regulatory certification processes but that the company says that these are not expected to impact the remaining quarters of 2019.

With the EBITDA in-line, Leung figures better-than-expected gross margins at 26.6 per cent over Q1, which he says should improve in Q2.

“Overall, we are very pleased with the strong margin improvement, which we expect to continue as revenues scale. We are increasing our target to $5.50 (was $5.00), which is based on 9x FY19 EV/EBITDA,” says Leung.

The analyst says that he will include in his estimates contributions from the previously announced acquisition of a US-based circuit board manufacturing company once the deal closes. Until then, his estimates are revenue and EBITDA for fiscal 2019 of $111.6 million and $15.4 million, respectively.

Leung’s $5.50 target represents a projected return of 68 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: ftg
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Magellan Aerospace stock a buy?

Its first quarter results are in the books and Paradigm Capital analyst J Marvin Wolff thinks there is money to… [Read More]

20 hours ago

Phunware is undervalued, Roth says

Ahead of the company's first quarter results, Roth MKM analyst Darren Aftahi thinks there is money to be made on… [Read More]

22 hours ago

Héroux-Devtek is a buy, Desjardins says

Ahead of the company's quarterly results, Desjardins Securities analyst Benoit Poirier likes what he sees from Héroux-Devtek (Héroux-Devtek Stock Quote,… [Read More]

23 hours ago

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

2 days ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

2 days ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

2 days ago